TY - JOUR
T1 - Diagnosis of human papillomavirus gynecologic infections
AU - Wick, M. J.
N1 - Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2000
Y1 - 2000
N2 - The identification in the early 1980s of human papillomavirus (HPV) DNA in cervical carcinoma generated interest in molecular classification of the virus, and prompted studies regarding the oncogenic potential of genital HPVs. Subsequent studies confirming the presence of HPV in greater than 90% of precancerous cervical lesions and close to 100% of cervical cancers has raised concerns regarding the adequacy of Papanicolaou (Pap) smear testing for the detection of precancerous lesions/HPV infection. A variety of detection methods adjunctive to cytologic testing have been described, including detection at the macroscopic level, cerviography, colposcopy, and serologic and molecular-based HPV testing. Recently, there has been intense interest in molecular-based detection and typing of HPV-induced genital lesions. This has resulted in the development of a variety of molecular-based detection methods including Southern transfer, dot blotting, in situ hybridization, hybrid capture, and PCR-based assays. This article provides an overview of each of the molecular methods, and addresses the potential future role of molecular-based HPV testing.
AB - The identification in the early 1980s of human papillomavirus (HPV) DNA in cervical carcinoma generated interest in molecular classification of the virus, and prompted studies regarding the oncogenic potential of genital HPVs. Subsequent studies confirming the presence of HPV in greater than 90% of precancerous cervical lesions and close to 100% of cervical cancers has raised concerns regarding the adequacy of Papanicolaou (Pap) smear testing for the detection of precancerous lesions/HPV infection. A variety of detection methods adjunctive to cytologic testing have been described, including detection at the macroscopic level, cerviography, colposcopy, and serologic and molecular-based HPV testing. Recently, there has been intense interest in molecular-based detection and typing of HPV-induced genital lesions. This has resulted in the development of a variety of molecular-based detection methods including Southern transfer, dot blotting, in situ hybridization, hybrid capture, and PCR-based assays. This article provides an overview of each of the molecular methods, and addresses the potential future role of molecular-based HPV testing.
UR - http://www.scopus.com/inward/record.url?scp=0033945169&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033945169&partnerID=8YFLogxK
U2 - 10.1016/s0272-2712(18)30062-3
DO - 10.1016/s0272-2712(18)30062-3
M3 - Review article
C2 - 10863641
AN - SCOPUS:0033945169
SN - 0272-2712
VL - 20
SP - 271
EP - 287
JO - Clinics in Laboratory Medicine
JF - Clinics in Laboratory Medicine
IS - 2
ER -